256 Newsroom — Uganda's Digital News Infrastructure
Health

Singapore group will develop 'most promising' Ebola vaccine

Share
Singapore group will develop 'most promising' Ebola vaccine
Image · CNA

What the report says

The Singapore-based Hilleman Laboratories announced it would advance the rVSV Bundibugyo jab so it can be tested on humans during clinical trials.

Read the full report at CNA →

Loading debate for this article…

Other publishers covering this story

No additional verified coverage is currently clustered with this report.

Related reporting